EN DE

Suli Co (603585) Fair Value & Analysis

Basic Materials · CN · Market cap 2.8B CNY

SC Suli Co 603585 · SHG
Price¥10.34
Fair Value¥16.64
Upside+60.9%
Quality56/100
Watch Suli Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 6.6% net margin
Low debt · negative free cash flow
2.54% dividend yield
Ranks above peers (10/12)
Narrow moat 37/100
Evidence: Medium Range ¥12.45 – ¥20.80 Share as image

Fair value as of: Aug 11, 2026

From 16 valuation models · updated today

Share price +10.5% over the past month.

A solid business, screening 61% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (¥12.45). The market is more pessimistic than our downside scenario.
  • Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥26.40 ¥9.11 Fair Value ¥16.64 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 11, 2026.

How to read this chart

60‑month range ¥9.11 – ¥26.40 · fair‑value band ¥12.45 – ¥20.80 · the ¥10.34 price screens below the ¥16.64 fair value. Dashed = 300-day average. As of Aug 11, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Suli Co (603585) currently trades at ¥10.34, while our model-based Fair Value estimate is ¥16.64, implying the stock looks roughly 60.9% undervalued today. The Quality Score stands at 56/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Suli Co generated revenue of 2.7B CNY at a net margin of 6.6%. Revenue declined 6.0% year over year. It earns a return on equity of 5.8%. Net debt stands at 915M CNY. Fundamentals as of Aug 11, 2026

Our scenario range runs from ¥12.45 (bear case) to ¥20.80 (bull case); at ¥10.34, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 62% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at 61%, 603585 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income ¥10.95 ¥11.43 ¥12.10 76
ROIC Compounder ¥8.90 ¥10.99 ¥12.80 72
Gordon GGM ¥0.9700 ¥1.93 ¥2.92 70
All 16 models by family
Earnings-Based
Graham-Dodd ¥6.66 ¥33.54 ¥46.31 54
Lynch FV ¥9.09 ¥12.99 ¥16.89 50
PEG = 1.0 ¥9.09 ¥12.99 ¥16.89 46
EPV ¥8.90 ¥10.99 ¥12.80 59
Dividend Discount
Gordon GGM ¥0.9700 ¥1.93 ¥2.92 70
DDM Multi-Stage ¥0.9700 ¥1.66 ¥2.03 61
Multiples
P/E Multiple ¥12.48 ¥16.64 ¥20.80 63
P/S Multiple ¥12.48 ¥16.64 ¥20.80 58
P/B Multiple ¥12.48 ¥16.64 ¥20.80 55
EV/EBIT ¥12.65 ¥18.32 ¥23.99 53
EV/EBITDA ¥19.60 ¥27.58 ¥35.56 54
EV/Revenue ¥10.39 ¥16.70 ¥23.01 43
Asset-Based
NCAV (Graham) ¥6.87 ¥9.21 ¥13.74 50
Economic Profit
Residual Income ¥10.95 ¥11.43 ¥12.10 76
ROIC Compounder ¥8.90 ¥10.99 ¥12.80 72
Growth Earnings
Growth-Adj P/E ¥12.45 ¥17.78 ¥23.11 68

Widest divergence: Growth Earnings (¥17.78) versus Dividend Discount (¥1.66). Highest evidence: Residual Income (76).

Notify me when 603585 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 2.7B CNY
Revenue growth (YoY) -6.0%
Net margin 6.6%
Return on equity 5.8%
Free cash flow −113M CNY FY2025
P/E ratio 15.6
More key figures
Operating margin 7.9%
EPS (TTM) ¥0.6500
Dividend yield 2.5%
EPS growth (YoY) -29.4%
Net debt 915M CNY FY2025

Figures from reported company fundamentals · as of Aug 11, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 56/100

Of which business quality 54 · Market factors (momentum, volatility) 17

Profitability 31
Margins and returns on capital today
Quality Growth 85
Are margins and returns improving?
Cashflow 40
Earnings quality: real cash, not paper profit
Fin. Strength 51
Balance sheet, leverage, solvency risk
Investment 63
Disciplined investing over empire-building
Low Volatility 54
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 4
Distance to the 52-week high (market factor)
Net Issuance 73
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Suli Co., Ltd. engages in the research, development, production, and sale of pesticides, flame retardants, and other fine chemical products. It offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane.

Full company description

Suli Co., Ltd. engages in the research, development, production, and sale of pesticides, flame retardants, and other fine chemical products. It offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. The company also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including pentachloropyridine, pentachlorobenzonitrile, isophthalonitrile, and hydrobromic acid, as well as diphenylethane and 1,2-dibromoethane. In addition, it offers industry biocides, such as Longee 985CHL, 550CCD, 550CC, and 500CHL; and calcium chloride and ferric chloride solution for use in water treatment. The company sells its products under the Suli brand name for use in agricultural production, plastics and building materials industries, medicine, and other fields in European Union, North America, South America, Africa, Southeast Asia, and other countries. The company was founded in 1994 and is headquartered in Jiangyin, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Suli Co reported revenue of ¥2.8B in FY2025 versus ¥2.3B in FY2021, a compound +4.3%/yr. Reported net income was ¥193M in FY2025, compounding −5.5%/yr from FY2021.

Growth Quality 48/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
2.8B CNY
Latest YoY
+20.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−4.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.2%
Avg. growth/yr (14Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.6%
Revenue +4.3%/yr
FY21 ¥2.3B
FY22 ¥3.2B
FY23 ¥2.0B
FY24 ¥2.3B
FY25 ¥2.8B
Net income −5.5%/yr
FY21 ¥241M
FY22 ¥315M
FY23 ¥20.1M
FY24 −¥10.8M
FY25 ¥193M
Character of growth · EPS growth decomposed (2013-2024) +3.9 % p.a.
Revenue per share +7.4 pp

of which total revenue +12.4 pp · buybacks/dilution −5.0 pp

EBIT margin −4.6 pp
Tax rate +0.4 pp
Residual (interest, one-offs) +0.7 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch 603585: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Suli Co Fair Value". https://www.fairvalue-calculator.com/stock/603585

Peer Group

Chemicals · 333 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 56 · Above median
Fair Value upside +61% · Top 25%
Return on equity (TTM) 6% · Above median
Return on assets 3% · Above median
Net margin (TTM) 7% · Above median
Operating margin (TTM) 8% · Above median
Revenue growth -6% · Below median
Debt / equity 0.47× · Higher than 75% of peers

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 16.7× · Cheaper than median
P/B 1.10× · Cheaper than median
P/S (TTM) 1.09× · Cheaper than median
EV/EBITDA 6.1× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 0
FUTURE 0 · sector 20
PAST 23 · sector 19
HEALTH 77 · sector 94
DIVIDEND 0 · sector 27

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 11, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare Suli Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Suli Co (603585) overvalued or undervalued?
As of Aug 11, 2026, our model estimates a fair value of ¥16.64 versus a price of ¥10.34, about +61% (undervalued).
What is the fair value of 603585?
Our model-based fair value for Suli Co is ¥16.64 (as of Aug 11, 2026), built from audited fundamentals. The current price is ¥10.34.
What is the quality score of 603585?
Suli Co has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Suli Co (603585)?
Suli Co reported trailing-twelve-month revenue of about 2.7B CNY (latest available figure, as of Aug 11, 2026).
What is the net profit margin of 603585?
The net profit margin of Suli Co is about 6.6%, meaning it keeps roughly 6.6% of revenue as net income. Based on the latest reported figures.
Does Suli Co pay a dividend?
Suli Co currently shows a dividend yield of about 2.54% relative to its recent price (as of Aug 11, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Suli Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.